Effects of Subclinical Hypothyroidism on Nephropathy Complicating Type 2 Diabetes: The Fremantle Diabetes Study Phase II
The Journal of Clinical Endocrinology & Metabolism · 2026
DOI: 10.1210/clinem/dgaf485 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2026. Verfasst von S A Paul Chubb und 2 weiteren Autor:innen. Beteiligte Einrichtung: Medical School, University of Western Australia, Fremantle Hospital, Fremantle, WA 6959, Australia. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Hypothyroidism, Diabetic Nephropathies. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council, Fremantle Hospital Medical Research Foundation.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Context
It is uncertain whether subclinical hypothyroidism (SCH) contributes to intrinsic renal dysfunction in people with type 2 diabetes mellitus (T2DM).
Objective
To investigate whether SCH persisting over 4 years is associated with incident impairment of renal function in people with T2DM.
Design
Longitudinal observational study.
Setting
Urban population of people with type 2 diabetes living in the community and enrolled in a prospective observational study of diabetes.
Participants
725 without known thyroid dysfunction at baseline and at follow-up. Main Outcome Measures Changes in estimated glomerular filtration rate (eGFR) and urine albumin:creatinine ratio (ACR) in participants stratified by thyroid status at baseline and follow-up into those with euthyroidism or transient or persistent subclinical (SCH)/overt hypothyroidism.
Results
After a mean ± SD 4.3 ± 0.4 years, 683 participants had stable euthyroidism, 18 transient SCH/overt hypothyroidism, and 24 persistent SCH/overt hypothyroidism. No significant changes in eGFR were observed in any group. Those with persistent SCH/overt hypothyroidism demonstrated a significant increase in ACR, which was not seen in those with euthyroidism and transient SCH/overt hypothyroidism (ΔACR 22.0 ± 81.4 vs 0.4 ± 36.7 and −0.3 ± 5.7 mg/mmol, respectively, P = .027). Similar results were seen when those with baseline ACR > 30 mg/mmol were excluded.
Conclusion
Persistent SCH/overt hypothyroidism was associated with incident increased albuminuria not observed in euthyroid participants. Assessment of thyroid function in all patients with T2DM may be indicated, as some previous studies provide evidence that thyroxine replacement may ameliorate albuminuria.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical School, University of Western Australia, Fremantle Hospital, Fremantle, WA 6959, Australia.
- Department of Endocrinology and Diabetes, Fiona Stanley and Fremantle Hospitals Group, Murdoch, WA 6150, Australia.
ORCID-Profile: Timothy M E Davis
Förderung
- National Health and Medical Research Council
- Fremantle Hospital Medical Research Foundation
Zitieren
APA
Chubb, S. A. P., Davis, W. A., & Davis, T. M. E. (2026). Effects of Subclinical Hypothyroidism on Nephropathy Complicating Type 2 Diabetes: The Fremantle Diabetes Study Phase II. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaf485
Vancouver
Chubb SAP, Davis WA, Davis TME. Effects of Subclinical Hypothyroidism on Nephropathy Complicating Type 2 Diabetes: The Fremantle Diabetes Study Phase II. The Journal of Clinical Endocrinology & Metabolism. 2026. doi:10.1210/clinem/dgaf485
BibTeX
@article{Chubb2026,
author = {Chubb, S A Paul and Davis, Wendy A and Davis, Timothy M E},
title = {Effects of Subclinical Hypothyroidism on Nephropathy Complicating Type 2 Diabetes: The Fremantle Diabetes Study Phase II},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2026},
doi = {10.1210/clinem/dgaf485}
}
EUVIMED